Literature DB >> 12807312

Antivenom treatment in arachnidism.

Geoffrey K Isbister1, Andis Graudins, Julian White, David Warrell.   

Abstract

Envenomation by arachnids causes significant medical illness worldwide. Scorpion sting is the most important arachnid envenomation causing adult morbidity and pediatric mortality. Important groups of spiders include the widow spiders (Latrodectus spp.), the recluse spiders (Loxosceles spp.), and two spiders confined to single countries: the Australian funnel web spider (Atrax and Hadronyche spp.) and the armed spider (Phoneutria spp.) from Brazil. There are four widow spider antivenoms available, including the Australian redback spider antivenom and the American black widow antivenom. Despite good in vitro animal work demonstrating effective neutralization with these antivenoms, and cross-reactivity between many species, there continues to be a reluctance to use them in some countries. They are both associated with a relatively low rate of allergic reactions. Redback antivenom is routinely used by the intramuscular route, which may not be as effective as intravenous use based on clinical experience and animal studies. Antivenoms are available for Loxosceles spp., but there is little evidence to support their effectiveness, particularly against local effects. The Australian funnel web spider causes severe neurotoxic envenomation, and antivenom appears to be effective in reported cases. An antivenom exists for the Brazilian armed spider, but is used in only a minority of cases. Many scorpion antivenoms exist worldwide, but there remains significant controversy regarding their efficacy. Animal and human venom level studies demonstrate neutralization of circulating venom in systemic envenomation. Clinical experience in countries where antivenom has been introduced suggests it has reduced pediatric mortality. However, three controlled trials demonstrated that antivenom was not effective, but these included few severe cases. Until controlled trials of antivenom in systemically envenomated patients are undertaken, antivenom use appears justified in severe envenomation. Although envenomation from arthropods is common, no antivenoms exist for these, excepting Lonomia caterpillars in South America, and Ixodes paralysis ticks in Australia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807312     DOI: 10.1081/clt-120021114

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  16 in total

1.  Low-dose ketamine provides poor analgesia for pain in redback spider envenoming.

Authors:  Nicole M Ryan; Rosemary James; Michael A Downes; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2019-08-06       Impact factor: 4.335

2.  Exploiting cross-reactivity to neutralize two different scorpion venoms with one single chain antibody fragment.

Authors:  Lidia Riaño-Umbarila; Gabriel Contreras-Ferrat; Timoteo Olamendi-Portugal; Citlalli Morelos-Juárez; Gerardo Corzo; Lourival D Possani; Baltazar Becerril
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

3.  Direct vs. mediated effects of scorpion venom: an experimental study of the effects of a second challenge with scorpion venom.

Authors:  Lamia Ouanes-Besbes; Souhail El Atrous; Semir Nouira; Nicolas Aubrey; Alain Carayon; Mohamed El Ayeb; Fekri Abroug
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

Review 4.  Pharmacokinetic considerations in clinical toxicology: clinical applications.

Authors:  Darren M Roberts; Nick A Buckley
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

5.  A comparison of serum antivenom concentrations after intravenous and intramuscular administration of redback (widow) spider antivenom.

Authors:  Geoffrey K Isbister; Margaret O'Leary; Mark Miller; Simon G A Brown; Sharmaine Ramasamy; Rosemary James; Jennifer S Schneider
Journal:  Br J Clin Pharmacol       Date:  2007-08-09       Impact factor: 4.335

6.  Mass landscapes of seven scorpion species: The first analyses of Australian species with 1,5-DAN matrix.

Authors:  Jennifer J Smith; Alun Jones; Paul F Alewood
Journal:  J Venom Res       Date:  2012-10-23

Review 7.  Epidemiological review of scorpion envenomation in iran.

Authors:  Amir Jalali; Fakher Rahim
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

8.  Antibacterial activity of the venom of Heterometrus xanthopus.

Authors:  Umair Ahmed; Malik Mujaddad-Ur-Rehman; Nauman Khalid; Sardar Atiq Fawad; Anees Fatima
Journal:  Indian J Pharmacol       Date:  2012 Jul-Aug       Impact factor: 1.200

Review 9.  Poisonous Spiders: Bites, Symptoms, and Treatment; an Educational Review.

Authors:  Farzad Rahmani; Seyed Mahdi Banan Khojasteh; Hanieh Ebrahimi Bakhtavar; Farnaz Rahmani; Kavous Shahsavari Nia; Gholamreza Faridaalaee
Journal:  Emerg (Tehran)       Date:  2014

10.  Low Health System Performance, Indigenous Status and Antivenom Underdosage Correlate with Spider Envenoming Severity in the Remote Brazilian Amazon.

Authors:  Vanderson Souza Sampaio; André Alexandre Gomes; Iran Mendonça Silva; Jacqueline Sachett; Luiz Carlos Lima Ferreira; Sâmella Oliveira; Meritxell Sabidò; Hipócrates Chalkidis; Maria Graças Vale Barbosa Guerra; Jorge Luis Salinas; Fan Hui Wen; Marcus Vinícius Guimarães Lacerda; Wuelton Marcelo Monteiro
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.